Emily  Borders , Pharm.D., BCOP

Assistant Professor

Department of Pharmacy: Clinical and Administrative Sciences

Phone (405) 271-6878  x47824
Office   CPB 213

Research Summary

Hammatology/oncology, blood and marrow transplantation
Research Interests
Supportive care in oncology, prevention and management of drug-related toxicities

Education & Experience

  • Doctor of Pharmacy. The University of Oklahoma College of Pharmacy, Oklahoma City, OK
  • Pharmacy Practice Residency (PGY1), The University of Oklahoma College of Pharmacy, Oklahoma City, OK (2006-2007)
  • Oncology Pharmacy Practice Residency (PGY2), The University of Kentucky Chandler Medical Center, Lexington, KY (2007-2008)

Teaching Experience

  • PHAR 7883: Hematology/Oncology module
  • PHAR 7813: Pharmaceutical Care I

Honors & Service


  • Oklahoma Society of Health-System Pharmacists. Treasurer
  • Hematology/Oncology Pharmacy Association
  • American College of Clinical Pharmacy
  • American Society of Health-System Pharmacists
  • American Association of Colleges of Pharmacy
view full profile

Selected Publications & Presentations

  1. Borders E, Medina P J. Colorectal Cancer McGraw-Hill. 2016;
  2. Borders E, Medina P J,. Colorectal Cancer Case McGraw-Hill. 2016;
  3. Borders E, Hopps S, Conway S E. Drug-drug interactions between warfarin and chemotherapy: A review of the literature In Press;
  4. Hopps S, Borders E, Hagemann T M. Prophylaxis and Treatment Recommendations for sinusoidal obstruction syndrome (SOS) in Adjult and Pediatric Patients undergoing Hematopoietic stem Cell Transplant (HSCT), a Review of the Literature J Oncol Pharm Pract. 2015;
  5. Srour S, Borders E, Cherry M, Holter-Chakrabarty J, Herman T, Selby G. Role of topotecan, vinorelbine, thiotepa, and gemcitabine (TVTG) chemotherapy in relapsed/refractory adult acute leukemia Leukemia and Lymphoma. 2015;
  6. show more